[1]
“MOLECULAR DOCKING AND MM/GBSA BINDING FREE ENERGY EVALUATION OF NAPROXEN-AZETIDINONE HYBRID DERIVATIVES AS POTENTIAL PREFERENTIAL COX-2 INHIBITORS: COMPARATIVE STUDY WITH MELOXICAM, ISORHAMNETIN, AND NAPROXEN FOR OSTEOARTHRITIS”, IPSSJ, vol. 3, no. 06 Juni, pp. 4621–4635, Jun. 2026, Accessed: Oct. 21, 2026. [Online]. Available: https://ipssj.com/index.php/ojs/article/view/1632